1. Technical Field
The present disclosure relates generally to treating a wound with negative or reduced pressure. In particular, the disclosure relates to a dressing having a vacuum port configured to receive a fluid conduit thereby connecting the dressing to a vacuum source.
2. Background of Related Art
Various techniques to promote healing of a wound involve providing suction to the wound. For example, a vacuum source may serve to carry wound exudates away from the wound, which may otherwise harbor bacteria that inhibit the body's natural healing process. One technique for promoting the natural healing process may be described as negative wound pressure therapy (NWPT). This technique involves the application of a reduced pressure, e.g. sub-atmospheric, to a localized reservoir over a wound. Sub-atmospheric pressure has been found to assist in closing the wound by promoting blood flow to the area, which stimulates the formation of granulation tissue and the migration of healthy tissue over the wound. This technique has proven effective for chronic or non-healing wounds, but has also been used for other purposes such as post-operative wound care.
The general NWPT protocol provides for covering the wound with a flexible cover layer such as a polymeric film, for example, to establish a vacuum reservoir over the wound where a reduced pressure may be applied by individual or cyclic evacuation procedures. To allow the reduced pressure to be maintained over time, the cover layer may include an adhesive periphery that forms a substantially fluid tight seal with the healthy skin surrounding the wound.
Although some procedures may employ a micro-pump contained within the vacuum reservoir, most NWPT treatments apply a reduced pressure using an external vacuum source. Thus, fluid communication between the vacuum source and the reservoir must be established. To this end, a cover layer will often be coupled to a vacuum port to which a fluid conduit extending from an external vacuum source may be connected. Once connected, the fluid conduit may extend from the vacuum port in an awkward direction that compromises patient movement or comfort. Accordingly, a need exists for a wound dressing for receiving a fluid conduit from a plurality of directions.
The present disclosure describes a wound dressing for use in a negative wound pressure therapy treatment. The wound dressing includes a cover layer for positioning over a wound to define a reservoir over the wound in which a reduced pressure may be maintained. At least one vacuum port is affixed to the cover layer and includes a conduit receiving portion configured to receive a fluid conduit to provide fluid communication between the fluid conduit and the reservoir. The at least one vacuum port is configured to receive the fluid conduit from a plurality of directions relative to the cover layer.
The at least one vacuum port may include a base configured to remain stationary relative to the cover layer and a conduit receiving portion adapted for rotational movement relative to the stationary base. The at least one vacuum port may include an orientation fixation structure configured to lock the conduit receiving portion in position relative to the stationary base in a releasable manner. The orientation fixation structure may include a pawl on one of the stationary base and the conduit receiving portion configured to interface with a series of spaced ridges or detents on the other of the stationary base and the conduit receiving portion in a ratchet-like manner. Alternatively, the orientation fixation structure may include a plurality or radially spaced projections extending from the stationary base radially beyond the conduit receiving portion so as to define a plurality of radially spaced slots therebetween. The slots may be configured to receive the fluid conduit.
The at least one vacuum port may also include a plurality of vacuum ports. Each of the plurality of vacuum ports may have a conduit receiving portion oriented relative to the cover layer to receive the fluid conduit in a direction differing from another of the plurality of vacuum ports. The plurality of vacuum ports may include a pair of vacuum ports oriented such that a pair of conduit receiving portions may receive the fluid conduit in orthogonal directions. The wound dressing may further include at least one plug removably coupled to the conduit receiving portion of one of the plurality of vacuum ports. The plug may be configured to selectively form a substantially fluid-tight seal with the conduit receiving portion of the one of the plurality of vacuum ports.
The at least one vacuum port comprises a conduit receiving portion having a plurality of entry paths, each entry path oriented relative to the cover layer to receive the fluid conduit in a direction differing from another of the plurality of entry paths. The wound dressing may further include at least one plug removably coupled to one of the plurality of entry paths. The plug may be configured to form a substantially fluid-tight seal with the one of the plurality of entry paths. The at least one vacuum port may also include a flange extending radially from a central portion of the at least one vacuum port to facilitate the formation of a fluid-tight connection with the cover layer. The flange may comprise a plurality of vents formed therein.
The wound dressing may include a vacuum port having a base exhibiting a radial symmetry, and a conduit receiving portion that is selectively removable and selectively engaged by the base in a plurality of orientations. The conduit receiving portion may include an annular lip or notch, and the base may include an annular lip or notch such that the conduit receiving portion and the base are adapted for snap-fit engagement. The base may also include a socket mount configured to receive a bulbous end of the conduit receiving portion. The socket mount may be segmented to define a plurality of radially spaced slots on the base, and each of the slots may be configured to engage the conduit receiving portion to maintain an orientation of the conduit receiving portion. The bulbous end of the conduit receiving portion may include an o-ring for sealing a passageway through the base.
According to another aspect of the disclosure, a negative wound pressure therapy apparatus includes a cover layer for defining a reservoir over a wound in which a negative pressure may be maintained by forming a substantially fluid-tight seal around the wound. A vacuum source suitable for providing an appropriate negative pressure to the reservoir to stimulate healing of the wound and a fluid conduit in fluid communication with the vacuum source are provided. Also, the apparatus includes at least one vacuum port coupled to the cover layer and comprises a conduit receiving portion configured to receive the fluid conduit to provide fluid communication between the fluid conduit and the reservoir. The at least one vacuum port is configured to receive the fluid conduit from a plurality of directions relative to the cover layer. The apparatus may further include a contact layer in direct contact with the wound and a wound filler positioned between the contact layer and the cover layer.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the present disclosure and, together with the detailed description of the embodiments given below, serve to explain the principles of the disclosure.
The attached figures illustrate exemplary embodiments of the present disclosure and are referenced to describe the embodiments depicted therein. Hereinafter, the disclosure will be described in detail by explaining the figures wherein like reference numerals represent like parts throughout the several views.
Referring initially to
Wound dressing 12 includes a contact layer 18 positioned in direct contact with the bed of wound “w” and may be formed from perforated film material. An appropriate perforated material permits the negative pressure applied to the reservoir to penetrate into the wound “w,” and also permits exudates to be drawn through the contact layer 18. Passage of wound fluid through the contact layer 18 is preferably unidirectional such that exudates do not flow back into the wound bed. Unidirectional flow may be encouraged by conical or directional apertures formed in the contact layer 18, or a lamination of materials having absorption properties differing from those of contact layer 18. A non-adherent material may be selected such that contact layer 18 does not tend to cling to the wound “w” or surrounding tissue when it is removed. One exemplary material that may be used as a contact layer 18 is sold under the trademark CURITY™ Non-Adhering Dressing by Kendall Corp., a division of Covidien.
Wound filler 20 is positioned in the wound “w” over the contact layer 18 and is intended to allow wound dressing 12 to transport wound exudates. Wound filler 20 can be cut to a shape that is conformable to the shape of wound “w,” and may be packed up to the level of healthy skin “s,” or alternatively, wound filler 20 may overfill the wound “w.” A filler material such as gauze, reticulated foam, or alginate fibers may be used for filler 20 to receive or transport any exudate that migrates through contact layer 18. An antimicrobial dressing sold under the trademark KERLIX® AMD by Tyco Healthcare Group LP (d/b/a Covidien), may be suitable for use as filler 20.
Wound dressing 12 also includes a cover layer 24. Cover layer 24 may be positioned over the wound “w” such that an adhesive on an underside of the cover layer forms a substantially fluid-tight seal with the surrounding skin “s.” Thus, cover layer 24 may act as both a microbial barrier to prevent contaminants from entering the wound “w,” and also a fluid barrier maintaining the integrity of vacuum reservoir 14. Cover layer 24 is preferably formed from a moisture vapor permeable membrane to promote the exchange of oxygen and moisture between the wound “w” and the atmosphere, and is preferably transparent to permit a visual assessment of wound conditions without requiring removal of the cover layer 24. A transparent membrane providing a sufficient moisture vapor transmission rate (MVTR) for use as cover layer 24 is sold under the trade name POLYSKIN®II by Tyco Healthcare Group LP (d/b/a Covidien). Alternatively, cover layer 24 may comprise an impermeable membrane or a substantially rigid member.
A vacuum port 30 having a flange 34 is provided to facilitate connection of the wound dressing 12 to fluid conduit 36. An opening in the cover layer 24 that is smaller than the flange 34 may be provided to permit fluid communication between the reservoir 14 and the vacuum port 30. As described in greater detail below with reference to
Fluid conduit 36 extends from the vacuum port 30 to provide fluid communication between the reservoir 14 and collection canister 40. Any suitable conduit may be used for fluid conduit 36 including those fabricated from flexible elastomeric or polymeric materials. Fluid conduit 36 may connect to the vacuum port 30, the canister 40, or other apparatus components by conventional air tight means such as friction fit, bayonet coupling, or barbed connectors. The conduit connections may be made permanent, or alternatively a quick-disconnect or other releasable means may be used to provide some adjustment flexibility to the apparatus 10.
Collection canister 40 may comprise any container suitable for containing wound fluids. For example, a rigid bottle may be used as shown or alternatively a flexible polymeric pouch may be appropriate. Collection canister 40 may contain an absorbent material to consolidate or contain the wound drainage or debris. For example, super absorbent polymers (SAP), silica gel, sodium polyacrylate, potassium polyacrylamide or related compounds may be provided within canister 40. At least a portion of canister 40 may be transparent to assist in evaluating the color, quality or quantity of wound exudates. A transparent canister may thus assist in determining the remaining capacity of the canister or when the canister should be replaced.
Leading from collection canister 40 is another section of fluid conduit 36 providing fluid communication with vacuum source 50. Vacuum source 50 generates or otherwise provides a negative pressure to the NWPT apparatus 10. Vacuum source 50 may comprise a peristaltic pump, a diaphragmatic pump or other mechanism that is biocompatible and draws fluids, e.g. atmospheric gasses and wound exudates, from the reservoir 14 appropriate to stimulate healing of the wound “w.” Preferably, the vacuum source 50 is adapted to produce a sub-atmospheric pressure in the reservoir 14 ranging between about 20 mmHg and about 500 mmHg, more preferably, about 75 mmHg to about 125 mmHg, or more preferably between about 40 mmHg to about 80 mmHg.
Referring now to
The size, shape and location of the wound “w” may influence the manner in which fluid conduit 36 is routed relative to the wound dressing 12. For example, cover layer 24 assumes a generally rectangular shape with two longer sides “l” and two minor sides “m” to effectively cover the wound “w.” Fluid conduit 36 extends from vacuum port 30 in a direction toward one of the minor sides “m” of the cover layer 24. Thus, flexible conduit 36 may continue up the patient's leg toward the canister 40 and vacuum source 50 without any unnecessary windings or flexures that could tend to kink the tubing. In other arrangements, such as the one depicted in
Referring now to
Wound dressing 112 exhibits a symmetry that permits fluid conduit 136 to extend from vacuum port 130 in a proper direction. The dressing 112 may be placed over the wound “w” in the orientation most suitable for routing the fluid conduit 136 with little or no impact on the relative positioning of the limbs 152. When the size, shape or position of a wound “w” does not allow for this symmetry, another type of conduit connection may be necessary.
Referring now to
As depicted in
Preferably, conduit receiving portion 262 may rotate at least 360 degrees in either direction. Vacuum port 230 may be configured such that conduit receiving portion 262 rotates through its range of motion freely, or alternatively vacuum port 230 may incorporate an orientation fixation structure (not shown) to releasably lock conduit receiving portion 262 in position relative to the base 264. For example, either the conduit receiving portion 262 or the base 264 may be equipped with a series of spaced ridges or detents arranged along a path corresponding to the range of motion of the conduit receiving portion. The other of the conduit receiving portion 262 and the base 264 may be equipped with a flexible pawl to interface with the spaced ridges or detents in a ratchet-like manner. Thus, conduit receiving portion 262 may tend to remain in position until purposely acted upon to rotate.
Referring now to
Referring now to
Referring now to
A plurality of circular vents 570 extend through the flange 568 and provide a pathway for moisture vapor transmission. The vents 570 allow for flange 568 to cover a larger area of the cover layer 524 with less impact on the MVTR associated with the dressing 512. A relatively larger flange 568 may be capable of providing a more secure seal with the cover layer 524 and thus enhance the effectiveness of an NWPT treatment. Additionally, vents 570 provide a degree of flexibility to the flange 568 that allows the flange 568 to conform to the particular contours of a body part. This flexibility promotes patient comfort.
Referring now to
The base 664 includes a flange 668 extending radially outward from a central passageway 670. The flange 688 provides broad upper and lower adhesion surfaces, 672 and 674 respectively, to facilitate connection with a cover layer. The passageway 670 provides fluid communication through the base 664 and also receives the conduit receiving portion 662. An annular lip 676 extending into the passageway 670 provides an interface for an annular notch 680 on the conduit receiving portion 662. Both the annular lip 676 and the annular notch 680 exhibit radial symmetry such that a conduit interface 684 may be oriented in any radial direction with respect to the base 664. As depicted in
Referring now to
As depicted in
Referring now to
Referring now to
Although the foregoing disclosure has been described in some detail by way of illustration and example, for purposes of clarity or understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
3367332 | Groves | Feb 1968 | A |
3486504 | Austin, Jr. | Dec 1969 | A |
3572340 | Lloyd et al. | Mar 1971 | A |
3712298 | Snowdon et al. | Jan 1973 | A |
3809086 | Schachet et al. | May 1974 | A |
3874387 | Barbieri | Apr 1975 | A |
4080970 | Miller | Mar 1978 | A |
4112947 | Nehring | Sep 1978 | A |
4112949 | Rosenthal et al. | Sep 1978 | A |
4136696 | Nehring | Jan 1979 | A |
4266545 | Moss | May 1981 | A |
4382441 | Svedman | May 1983 | A |
4524064 | Nambu | Jun 1985 | A |
4743232 | Kruger | May 1988 | A |
4969880 | Zamierowski | Nov 1990 | A |
4990137 | Graham | Feb 1991 | A |
4997438 | Nipper | Mar 1991 | A |
5071409 | Rosenberg | Dec 1991 | A |
5100395 | Rosenberg | Mar 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5106629 | Cartmell et al. | Apr 1992 | A |
5141503 | Sewell, Jr. | Aug 1992 | A |
5149331 | Ferdman et al. | Sep 1992 | A |
5152757 | Eriksson | Oct 1992 | A |
5160322 | Scheremet et al. | Nov 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5178157 | Fanlo | Jan 1993 | A |
5195977 | Pollitt | Mar 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5263922 | Sova et al. | Nov 1993 | A |
D364679 | Heaton et al. | Nov 1995 | S |
5484427 | Gibbons | Jan 1996 | A |
5527293 | Zamierowski | Jun 1996 | A |
5536233 | Khouri | Jul 1996 | A |
5549584 | Gross | Aug 1996 | A |
5588958 | Cunningham et al. | Dec 1996 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
5678564 | Lawrence et al. | Oct 1997 | A |
5701917 | Khouri | Dec 1997 | A |
5733305 | Fleischmann | Mar 1998 | A |
5840049 | Tumey et al. | Nov 1998 | A |
5911222 | Lawrence et al. | Jun 1999 | A |
5944703 | Dixon et al. | Aug 1999 | A |
6010524 | Fleischmann | Jan 2000 | A |
6071267 | Zamierowski | Jun 2000 | A |
6117111 | Fleischmann | Sep 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
D434150 | Tumey et al. | Nov 2000 | S |
6142982 | Hunt et al. | Nov 2000 | A |
6174306 | Fleischmann | Jan 2001 | B1 |
6203563 | Fernandez | Mar 2001 | B1 |
6261276 | Reitsma | Jul 2001 | B1 |
6325788 | McKay | Dec 2001 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6348423 | Griffiths et al. | Feb 2002 | B1 |
6398767 | Fleischmann | Jun 2002 | B1 |
6406447 | Thrash et al. | Jun 2002 | B1 |
6420622 | Johnston et al. | Jul 2002 | B1 |
6458109 | Henley et al. | Oct 2002 | B1 |
6488643 | Tumey et al. | Dec 2002 | B1 |
6500112 | Khouri | Dec 2002 | B1 |
D469175 | Hall et al. | Jan 2003 | S |
D469176 | Hall et al. | Jan 2003 | S |
6520982 | Boynton et al. | Feb 2003 | B1 |
6553998 | Heaton et al. | Apr 2003 | B2 |
D475134 | Randolph | May 2003 | S |
6557704 | Randolph | May 2003 | B1 |
D478659 | Hall et al. | Aug 2003 | S |
6607495 | Skalak et al. | Aug 2003 | B1 |
6626891 | Ohmstede | Sep 2003 | B2 |
6648862 | Watson | Nov 2003 | B2 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6695823 | Lina et al. | Feb 2004 | B1 |
6695824 | Howard et al. | Feb 2004 | B2 |
D488558 | Hall | Apr 2004 | S |
6752794 | Lockwood et al. | Jun 2004 | B2 |
6755807 | Risk, Jr. et al. | Jun 2004 | B2 |
6764462 | Risk, Jr. et al. | Jul 2004 | B2 |
6767334 | Randolph | Jul 2004 | B1 |
6800074 | Henley et al. | Oct 2004 | B2 |
6814079 | Heaton et al. | Nov 2004 | B2 |
6824533 | Risk, Jr. et al. | Nov 2004 | B2 |
6855135 | Lockwood et al. | Feb 2005 | B2 |
6856821 | Johnson | Feb 2005 | B2 |
6887228 | McKay | May 2005 | B2 |
6887263 | Bleam et al. | May 2005 | B2 |
6936037 | Bubb et al. | Aug 2005 | B2 |
6942633 | Odland | Sep 2005 | B2 |
6942634 | Odland | Sep 2005 | B2 |
6951553 | Bubb et al. | Oct 2005 | B2 |
6960181 | Stevens | Nov 2005 | B2 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
6994702 | Johnson | Feb 2006 | B1 |
7022113 | Lockwood et al. | Apr 2006 | B2 |
7037254 | O'Connor et al. | May 2006 | B2 |
7052167 | Vanderschuit | May 2006 | B2 |
7070584 | Johnson et al. | Jul 2006 | B2 |
7077832 | Fleischmann | Jul 2006 | B2 |
7108683 | Zamierowski | Sep 2006 | B2 |
7117869 | Heaton et al. | Oct 2006 | B2 |
7128719 | Rosenberg | Oct 2006 | B2 |
7128735 | Weston | Oct 2006 | B2 |
7144390 | Hannigan et al. | Dec 2006 | B1 |
7169151 | Lytinas | Jan 2007 | B1 |
7182758 | McCraw | Feb 2007 | B2 |
7195624 | Lockwood et al. | Mar 2007 | B2 |
7198046 | Argenta et al. | Apr 2007 | B1 |
7214202 | Vogel et al. | May 2007 | B1 |
7216651 | Argenta et al. | May 2007 | B2 |
D544092 | Lewis | Jun 2007 | S |
7273054 | Heaton et al. | Sep 2007 | B2 |
7276051 | Henley et al. | Oct 2007 | B1 |
7279612 | Heaton et al. | Oct 2007 | B1 |
7316672 | Hunt et al. | Jan 2008 | B1 |
D565177 | Locke et al. | Mar 2008 | S |
7338482 | Lockwood et al. | Mar 2008 | B2 |
7351250 | Zamierowski | Apr 2008 | B2 |
7361184 | Joshi | Apr 2008 | B2 |
7381211 | Zamierowski | Jun 2008 | B2 |
7381859 | Hunt et al. | Jun 2008 | B2 |
7396345 | Knighton et al. | Jul 2008 | B2 |
7410495 | Zamierowski | Aug 2008 | B2 |
7413570 | Zamierowski | Aug 2008 | B2 |
7413571 | Zamierowski | Aug 2008 | B2 |
7422576 | Boynton et al. | Sep 2008 | B2 |
20010031943 | Urie | Oct 2001 | A1 |
20010043943 | Coffey | Nov 2001 | A1 |
20020016577 | Ohmstede | Feb 2002 | A1 |
20020108614 | Schultz | Aug 2002 | A1 |
20020143286 | Tumey | Oct 2002 | A1 |
20020151836 | Burden | Oct 2002 | A1 |
20030093041 | Risk, Jr. et al. | May 2003 | A1 |
20030208149 | Coffey | Nov 2003 | A1 |
20030212357 | Pace | Nov 2003 | A1 |
20030212359 | Butler | Nov 2003 | A1 |
20030219469 | Johnson et al. | Nov 2003 | A1 |
20040006319 | Lina et al. | Jan 2004 | A1 |
20040030304 | Hunt et al. | Feb 2004 | A1 |
20040039415 | Zamierowski | Feb 2004 | A1 |
20040064132 | Boehringer et al. | Apr 2004 | A1 |
20040073151 | Weston | Apr 2004 | A1 |
20040093026 | Weidenhagen et al. | May 2004 | A1 |
20040122434 | Argenta et al. | Jun 2004 | A1 |
20040193218 | Butler | Sep 2004 | A1 |
20040241213 | Bray | Dec 2004 | A1 |
20040243073 | Lockwood et al. | Dec 2004 | A1 |
20050010153 | Lockwood et al. | Jan 2005 | A1 |
20050020955 | Sanders et al. | Jan 2005 | A1 |
20050070835 | Joshi | Mar 2005 | A1 |
20050070858 | Lockwood et al. | Mar 2005 | A1 |
20050085795 | Lockwood et al. | Apr 2005 | A1 |
20050131327 | Lockwood et al. | Jun 2005 | A1 |
20050177190 | Zamierowski | Aug 2005 | A1 |
20050182445 | Zamierowski | Aug 2005 | A1 |
20050222527 | Miller et al. | Oct 2005 | A1 |
20050222544 | Weston | Oct 2005 | A1 |
20050261642 | Weston | Nov 2005 | A1 |
20050261643 | Bybordi et al. | Nov 2005 | A1 |
20060015087 | Risk et al. | Jan 2006 | A1 |
20060025727 | Boehringer et al. | Feb 2006 | A1 |
20060039742 | Cable, Jr. et al. | Feb 2006 | A1 |
20060041247 | Petrosenko et al. | Feb 2006 | A1 |
20060079852 | Bubb et al. | Apr 2006 | A1 |
20060100586 | Karpowicz et al. | May 2006 | A1 |
20060100594 | Adams et al. | May 2006 | A1 |
20060116620 | Oyaski | Jun 2006 | A1 |
20070014837 | Johnson et al. | Jan 2007 | A1 |
20070021697 | Ginther et al. | Jan 2007 | A1 |
20070027414 | Hoffman et al. | Feb 2007 | A1 |
20070032754 | Walsh | Feb 2007 | A1 |
20070032755 | Walsh | Feb 2007 | A1 |
20070032778 | Heaton et al. | Feb 2007 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070066946 | Haggstrom et al. | Mar 2007 | A1 |
20070078366 | Haggstrom et al. | Apr 2007 | A1 |
20070078432 | Halseth et al. | Apr 2007 | A1 |
Number | Date | Country |
---|---|---|
41 11 122 | Apr 1993 | DE |
295 04 378 | Oct 1995 | DE |
43 06 478 | Dec 2008 | DE |
0 020 662 | Jul 1984 | EP |
0 358 302 | Mar 1990 | EP |
0 853 950 | Oct 2002 | EP |
1 549 756 | Mar 1977 | GB |
2 195 255 | Apr 1988 | GB |
2 235 877 | Mar 1991 | GB |
1762940 | Jan 1989 | SU |
8001139 | Jun 1980 | WO |
8002182 | Oct 1980 | WO |
8401904 | May 1984 | WO |
8905133 | Jun 1989 | WO |
9011795 | Oct 1990 | WO |
9219313 | Nov 1992 | WO |
9605873 | Feb 1996 | WO |
9605873 | Feb 1996 | WO |
03057307 | Jul 2003 | WO |
03101508 | Dec 2003 | WO |
2005009488 | Feb 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20100191197 A1 | Jul 2010 | US |